Sabre Insur Regulatory News (SBRE)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT

For Immediate Release

 11 December 2017

SABRE INSURANCE GROUP PLC

Admission to trading on the London Stock Exchange

Further to its announcement on 6 December 2017 relating to the initial public offering of its ordinary shares (the "Offer"), Sabre is pleased to announce that its entire ordinary share capital of 250,000,000 Shares has today been admitted to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities under the ticker "SBRE".

Enquiries

Ticker: SBRE

SEDOL: BYWVDP4

ISIN: GB00BYWVDP49

LEI: 2138006RXRQ8P8VKGV98

Important Notice

Neither this announcement nor any copy of it may be made or transmitted into the United States of America, or distributed, directly or indirectly, in the United States of America. Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, Japan or South Africa or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States of America, Australia, Canada, Japan or South Africa or in any jurisdiction in which such offer or solicitation is unlawful.

The securities referred to herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States of America and may not be offered or sold in the United States of America except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with such other applicable laws. There will be no public offering of the securities in the United States of America. The securities referred to herein have not been registered under the applicable securities laws of, Canada, Australia, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Canada, Australia, Japan or South Africa or to any national, resident or citizen of Canada, Australia, Japan or South Africa.

This announcement is not an offer of, or solicitation of an offer to buy or subscribe for, the securities referred to herein to any person in the United States of America or any other jurisdiction. This announcement is an advertisement and not a prospectus. Investors should not subscribe for or purchase any transferable securities referred to in this announcement except on the basis of information in the Prospectus, as supplemented by the Pricing Statement, published by Sabre in connection with the proposed admission of its Ordinary Shares to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange plc's main market for listed securities. Copies of the Prospectus and the Pricing Statement (when published) will be available for inspection from the Company's registered office at Sabre House, 150 South Street, Dorking, Surrey RH4 2YY and from the Company's website www.sabreplc.co.uk (subject to applicable securities laws).

Any purchase of Ordinary Shares in the Offer should be made solely on the basis of the information contained in the Prospectus, as supplemented by the Pricing Statement, published in connection with the Offer. Before purchasing any Ordinary Shares, persons viewing this announcement should ensure that they understand and accept fully the risks which are set out in the Prospectus. The information in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any Ordinary Shares or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor.

Barclays Bank PLC ("Barclays"), which is authorised in the United Kingdom by the Prudential Regulation Authority and regulated in the United Kingdom by the FCA and the Prudential Regulation Authority, and Numis Securities Limited ("Numis"), Evercore Partners International LLP ("Evercore") and Peel Hunt LLP ("Peel Hunt") which are authorised and regulated by the FCA in the United Kingdom, and Joh. Berenberg, Gossler & Co. KG ("Berenberg"), which is authorised by the German Financial Supervisory Authority and subject to limited regulation by the FCA, are acting exclusively for Sabre and no one else in connection with the Offer. They will not regard any other person as their respective clients in relation to the Offer and will not be responsible to anyone other than Sabre for providing the protections afforded to their respective clients, nor for providing advice in relation to the Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

In connection with the Offer, Barclays, Numis, Evercore, Berenberg and Peel Hunt, and any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase Ordinary Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Ordinary Shares and other securities of Sabre or related investments in connection with the Offer or otherwise. Accordingly, references in the Prospectus to the Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Barclays, Numis, Evercore, Berenberg and Peel Hunt, or any of their respective affiliates, acting as investors for their own accounts. In addition Barclays, Numis, Evercore, Berenberg and Peel Hunt may enter into financing arrangements with investors, such as share swap arrangements or lending arrangements where Ordinary Shares are used as collateral, that could result in Barclays, Numis, Evercore, Berenberg and Peel Hunt acquiring shareholdings in Sabre. None of Barclays, Numis, Evercore, Berenberg and Peel Hunt intends to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

Apart from the responsibilities and liabilities, if any, which may be imposed by the Financial Services and Markets Act 2000 (as amended) or the regulatory regime established thereunder, none of Barclays, Numis, Evercore, Berenberg and Peel Hunt, or any of their respective affiliates, directors, personally liable partners, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to Sabre, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available, or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.